Targets and Antibody Formats for Immunotherapy of Neuroblastoma.
Ontology highlight
ABSTRACT: Neuroblastoma (NB) is a malignant embryonal tumor of the sympathetic nervous system that is most commonly diagnosed in the abdomen, often presenting with signs and symptoms of metastatic spread. Three decades ago, high-risk NB metastatic to bone and bone marrow in children was not curable. Today, with multimodality treatment, 50% of these patients will survive, but most suffer from debilitating treatment-related complications. Novel targeted therapies to improve cure rates while minimizing toxicities are urgently needed. Recent molecular discoveries in oncology have spawned the development of an impressive array of targeted therapies for adult cancers, yet the paucity of recurrent somatic mutations or activated oncogenes in pediatric cancers poses a major challenge to the evolving paradigm
SUBMITTER: Park JA
PROVIDER: S-EPMC7255979 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA